- Active not recruiting
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
This study looks at how well certain eye medicines from Roche work for conditions like wet macular degeneration and diabetic eye disease in real patients. It's about understanding long-term results and why doctors choose specific treatments, without changing how patients are usually cared for.
For: Neovascular Age-related Macular Degeneration · Diabetic Macular Edema · Retinal Vein OcclusionUnited States · Argentina · Australia - Active not recruitingPHASE4
A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
This study is looking at a new treatment called faricimab for a common eye condition called 'wet' Age-related Macular Degeneration (AMD). It aims to see how well it works, if it's safe, and how long its effects last when given less often.
For: Neovascular Age-related Macular Degeneration (nAMD)United States · Australia · Canada - Active not recruitingPHASE4
Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial
This study is looking at new ways to treat diabetic macular edema, an eye condition caused by diabetes. It compares two different schedules for giving a new medicine called faricimab to see which works best for patients in their daily lives.
For: Diabetic Macular EdemaUnited States · Australia · Canada